αV integrin promotes in vitro and in vivo survival of cells in metastatic melanoma
Pekka Koistinen
MediCity Research Laboratory, University of Turku, Turku, Finland
Department of Medical Biochemistry, University of Turku, Turku, Finland
Turku Graduate School of Biomedical Sciences, University of Turku, Turku, Finland
Search for more papers by this authorMatti Ahonen
Center for Biotechnology, University of Turku, Turku, Finland
Search for more papers by this authorVeli-Matti Kähäri
Department of Medical Biochemistry, University of Turku, Turku, Finland
Center for Biotechnology, University of Turku, Turku, Finland
Department of Dermatology, University of Turku, Turku, Finland
Search for more papers by this authorCorresponding Author
Jyrki Heino
MediCity Research Laboratory, University of Turku, Turku, Finland
Department of Medical Biochemistry, University of Turku, Turku, Finland
Fax: +358-2-3337000
MediCity Research Laboratory, University of Turku, Tykistökatu 6A, FIN-20520 Turku, FinlandSearch for more papers by this authorPekka Koistinen
MediCity Research Laboratory, University of Turku, Turku, Finland
Department of Medical Biochemistry, University of Turku, Turku, Finland
Turku Graduate School of Biomedical Sciences, University of Turku, Turku, Finland
Search for more papers by this authorMatti Ahonen
Center for Biotechnology, University of Turku, Turku, Finland
Search for more papers by this authorVeli-Matti Kähäri
Department of Medical Biochemistry, University of Turku, Turku, Finland
Center for Biotechnology, University of Turku, Turku, Finland
Department of Dermatology, University of Turku, Turku, Finland
Search for more papers by this authorCorresponding Author
Jyrki Heino
MediCity Research Laboratory, University of Turku, Turku, Finland
Department of Medical Biochemistry, University of Turku, Turku, Finland
Fax: +358-2-3337000
MediCity Research Laboratory, University of Turku, Tykistökatu 6A, FIN-20520 Turku, FinlandSearch for more papers by this authorAbstract
The expression of integrin αV subunit on 4 melanoma-derived cell lines (A2058, SK-mel-5, WM-115 and WM-266-4) was analyzed. WM-115 cells, which originate from a primary tumor, were negative, whereas all 3 metastasis-derived lines had high levels of αV. To study αV integrins in the survival of melanoma cells, we developed a novel strategy that is exempt from extracellular inhibitors of ligand binding, which can activate integrin signaling and have integrin-independent effects on apoptosis. A recombinant adenovirus was used to transfer cDNA coding for a single-chain intracellular anti-αV integrin antibody into the melanoma cells. Anti-αV integrin adenovirus effectively inhibited the cell surface expression of αV integrins. In cell culture experiments, the depletion of αV integrins detached cells from extracellular matrix and induced apoptosis. Moreover, it prevented WM-266-4 cells from forming tumors in severe combined immunodeficiency mice but it could not prevent the growth of tumors that were formed by αV-negative WM-115 cells. Our results indicate that in primary melanomas there are cells that survive without αV integrins, whereas during the progression of disease cells can develop a dependency on these receptors. Furthermore, the data oppose the possibility that in melanoma cells apoptosis could occur due to direct activation of caspases by ligand-free αV integrins on the cell surface. © 2004 Wiley-Liss, Inc.
REFERENCES
- 1 Bader BL, Rayburn H, Crowley D, Hynes RO. Extensive vasculogenesis, angiogenesis, and organogenesis precede lethality in mice lacking all αV integrins. Cell 1998; 95: 507–19.
- 2 Hieken TJ, Farolan M, Ronan SG, Shilkaitis A, Wild L, Das Gupta TK. β3 integrin expression in melanoma predicts subsequent metastasis. J Surg Res 1996; 63: 169–73.
- 3
Gouon V,
Tucker GC,
Kraus-Berthier L,
Atassi G,
Kieffer N.
Up-regulated expression of the β3 integrin and the 92-kDa gelatinase in human HT-144 melanoma cell tumors grown in nude mice.
Int J Cancer
1996;
68:
650–62.
10.1002/(SICI)1097-0215(19961127)68:5<650::AID-IJC16>3.0.CO;2-5 CAS PubMed Web of Science® Google Scholar
- 4 Hsu MY, Shih DT, Meier FE, Van Belle P, Hsu JY, Elder DE, Buck CA, Herlyn M. Adenoviral gene transfer of β3 integrin subunit induces conversion from radial to vertical growth phase in primary human melanoma. Am J Pathol 1998; 153: 1435–42.
- 5
Hieken TJ,
Ronan SG,
Farolan M,
Shilkaitis AL,
Das Gupta TK.
Molecular prognostic markers in intermediate-thickness cutaneous malignant melanoma.
Cancer
1999;
85:
375–82.
10.1002/(SICI)1097-0142(19990115)85:2<375::AID-CNCR15>3.0.CO;2-1 CAS PubMed Web of Science® Google Scholar
- 6 Van Belle PA, Elenitsas R, Satyamoorthy K, Wolfe JT, Guerry DT, Schuchter L, Van Belle TJ, Albelda S, Tahin P, Herlyn M, Elder DE. Progression-related expression of β3 integrin in melanomas and nevi. Hum Pathol 1999; 30: 562–7.
- 7
Kageshita T,
Hamby CV,
Hirai S,
Kimura T,
Ono T,
Ferrone S.
Differential clinical significance of αVβ3 expression in primary lesions of acral lentiginous melanoma and of other melanoma histotypes.
Int J Cancer
2000;
89:
153—9.
10.1002/(SICI)1097-0215(20000320)89:2<153::AID-IJC9>3.0.CO;2-1 CAS PubMed Web of Science® Google Scholar
- 8 Sturm RA, Satyamoorthy K, Meier F, Gardiner BB, Smit DJ, Vaidya B, Herlyn M. Osteonectin/SPARC induction by ectopic β3 integrin in human radial growth phase primary melanoma cells. Cancer Res 2002; 62: 226–32.
- 9 Liapis H, Adler LM, Wick MR, Rader JS. Expression of αVβ3 integrin is less frequent in ovarian epithelial tumors of low malignant potential in contrast to ovarian carcinomas. Hum Pathol 1997; 28: 443–9.
- 10 Goldberg I, Davidson B, Reich R, Gotlieb WH, Ben-Baruch G, Bryne M, Berner A, Nesland JM, Kopolovic J. αV integrin expression is a novel marker of poor prognosis in advanced-stage ovarian carcinoma. Clin Cancer Res 2001; 7: 4073–9.
- 11 Chattopadhyay N, Chatterjee A. Studies on the expression of αVβ3 integrin receptors in non-malignant and malignant human cervical tumor tissues. J Exp Clin Cancer Res 2001; 20: 269–75.
- 12 Chen J, Baskerville C, Han Q, Pan ZK, Huang S. αV integrin, p38 mitogen-activated protein kinase, and urokinase plasminogen activator are functionally linked in invasive breast cancer cells. J Biol Chem 2001; 276: 47901–5.
- 13 Van Waes C, Enamorado-Ayala I, Hecht D, Sulica L, Chen Z, Batt DG, Mousa S. Effects of the novel αV integrin antagonist SM256 and cis-platinum on growth of murine squamous cell carcinoma PAM LY8. Int J Oncol 2000; 16: 1189–95.
- 14 Cooper CR, Chay CH, Pienta KJ. The role of αVβ3 in prostate cancer progression. Neoplasia 2002; 4: 191–4.
- 15 Geissinger E, Weisser C, Fischer P, Schartl M, Wellbrock C. Autocrine stimulation by osteopontin contributes to antiapoptotic signalling of melanocytes in dermal collagen. Cancer Res 2002; 62: 4820–8.
- 16 Montgomery AM, Reisfeld RA, Cheresh DA. Integrin alpha v beta 3 rescues melanoma cells from apoptosis in three-dimensional dermal collagen. Proc Natl Acad Sci USA 1994; 91: 8856–60.
- 17 Kozlova NI, Morozevich GE, Chubukina AN, Berman AE. Integrin αVβ3 promotes anchorage-dependent apoptosis in human intestinal carcinoma cells. Oncogene 2001; 20: 4710–7.
- 18 Stupack DG, Puente XS, Boutsaboualoy S, Storgard CM, Cheresh DA. Apoptosis of adherent cells by recruitment of caspase-8 to unligated integrins. J Cell Biol 2001; 155: 459–70.
- 19 MacDonald TJ, Ladisch S. Antisense to integrin αV inhibits growth and induces apoptosis in medulloblastoma cells. Anticancer Res 2001; 21: 3785–91.
- 20 Buckley CD, Pilling D, Henriquez NV, Parsonage G, Threlfall K, Scheel-Toellner D, Simmons DL, Akbar AN, Lord JM, Salmon M. RGD peptides induce apoptosis by direct caspase-3 activation. Nature 1999; 397: 534–9.
- 21 Wilkinson GW, Akrigg A. Constitutive and enhanced expression from the CMV major IE promoter in a defective adenovirus vector. Nucl Acids Res 1992; 20: 2233–9.
- 22 Koistinen P, Pulli T, Uitto VJ, Nissinen L, Hyypiä T, Heino J. Depletion of αV integrins from osteosarcoma cells by intracellular antibody expression induces bone differentiation marker genes and suppresses gelatinase (MMP-2) synthesis. Matrix Biol 1999; 18: 239–51.
- 23 Ahonen M, Baker AH, Kähäri V-M. Adenovirus-mediated gene delivery of tissue inhibitor of metalloproteinases-3 inhibits invasion and induces apoptosis in melanoma cells. Cancer Res 1998; 58: 2310–5.
- 24 Ala-aho R, Johansson N, Baker AH, Kähäri V-M. Expression of collagenase-3 (MMP-13) enhances invasion of human fibrosarcoma HT-1080 cells. Int J Cancer 2002; 97: 283–9.
- 25 Jaakkola P, Ahonen M, Kähäri V-M, Jalkanen M. Transcriptional targeting of adenoviral gene delivery into migrating wound keratinocytes using FiRE, a growth factor-inducible regulatory element. Gene Ther 2000; 7: 1640–7.
- 26 Lu Y, Zhang Y, Steiner MS. Efficient identification of recombinant adenoviruses by direct plaque screening. DNA Cell Biol 1998; 17: 643–5.
- 27 Koistinen P, Heino J. The selective regulation of αVβ1 integrin expression is based on the hierarchical formation of αV-containing heterodimers. J Biol Chem 2002; 277: 24835–41.
- 28 Pischel KD, Hemler ME, Huang C, Bluestein HG, Woods VL Jr. Use of the monoclonal antibody 12F1 to characterize the differentiation antigen VLA-2. J Immunol 1987; 138: 226–33.
- 29 Akiyama SK, Yamada SS, Chen WT, Yamada KM. Analysis of fibronectin receptor function with monoclonal antibodies: roles in cell adhesion, migration, matrix assembly, and cytoskeletal organization. J Cell Biol 1989; 109: 863–75.
- 30 Heino J, Ignotz RA, Hemler ME, Crouse C, Massague J. Regulation of cell adhesion receptors by transforming growth factor- beta: concomitant regulation of integrins that share a common β1 subunit. J Biol Chem 1989; 264: 380–8.
- 31 Weinacker A, Chen A, Agrez M, Cone RI, Nishimura S, Wayner E, Pytela R, Sheppard D. Role of the integrin αVβ6 in cell attachment to fibronectin: heterologous expression of intact and secreted forms of the receptor. J Biol Chem 1994; 269: 6940–8.
- 32 Furlanetto RW, Harwell SE, Baggs RB. Effects of insulin-like growth factor receptor inhibition on human melanomas in culture and in athymic mice. Cancer Res 1993; 53: 2522–6.
- 33 Wickham TJ, Mathias P, Cheresh DA, Nemerow GR. Integrins αVβ and αVβ5 promote adenovirus internalization but not virus attachment. Cell 1993; 73: 309–19.
- 34 Sheppard D, Cohen DS, Wang A, Busk M. Transforming growth factor beta differentially regulates expression of integrin subunits in guinea pig airway epithelial cells. J Biol Chem 1992; 267: 17409–14.
- 35 Albelda SM, Mette SA, Elder DE, Stewart R, Damjanovich L, Herlyn M, Buck CA. Integrin distribution in malignant melanoma: association of the β3 subunit with tumor progression. Cancer Res 1990; 50: 6757–64.
- 36 Li X, Chen B, Blystone SD, McHugh KP, Ross FP, Ramos DM. Differential expression of αV integrins in K1735 melanoma cells. Invas Metastasis 1998; 18: 1–14.
- 37 Brooks PC, Montgomery AM, Rosenfeld M, Reisfeld RA, Hu T, Klier G, Cheresh DA. Integrin αVβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 1994; 79: 1157–64.
- 38 Friedlander M, Brooks PC, Shaffer RW, Kincaid CM, Varner JA, Cheresh DA. Definition of two angiogenic pathways by distinct αV integrins. Science 1995; 270: 1500–2.
- 39 McCarty JH, Monahan-Earley RA, Brown LF, Keller M, Gerhard H, Rubin K, Shani M, Dvorak HF, Wolburg H, Bader BL, Dvorak AM, Hynes RO. Defective associations between blood vessels and brain parenchyma lead to cerebral hemorrhage in mice lacking αV integrins. Mol Cell Biol 2002; 22: 7667–77.
- 40 Reynolds LE, Wyder L, Lively JC, Taverna D, Robinson SD, Huang X, Sheppard D, Hynes RO, Hodivala-Dilke KM. Enhanced pathological angiogenesis in mice lacking β3 integrin or β3 and β5 integrins. Nat Med 2002; 8: 27–34.
- 41 Hynes RO. A reevaluation of integrins as regulators of angiogenesis. Nat Med 2002; 8: 918–21.
- 42 Strömblad S, Becker JC, Yebra M, Brooks PC, Cheresh DA. Suppression of p53 activity and p21WAF1/CIP1 expression by vascular cell integrin αVβ3 during angiogenesis. J Clin Invest 1996; 98: 426–33.
- 43 Kronenwett R, Graf T, Nedbal W, Weber M, Steidl U, Rohr UP, Mohler T, Haas R. Inhibition of angiogenesis in vitro by αV integrin-directed antisense oligonucleotides. Cancer Gene Ther 2002; 9: 587–96.
- 44 Bergelson JM, Cunningham JA, Droguett G, Kurt-Jones EA, Krithivas A, Hong JS, Horwitz MS, Crowell RL, Finberg RW. Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5. Science 1997; 275: 1320–3.
- 45 Bai M, Harfe B, Freimuth P. Mutations that alter an Arg-Gly-Asp (RGD) sequence in the adenovirus type 2 penton base protein abolish its cell-rounding activity and delay virus reproduction in flat cells. J Virol 1993; 67: 5198–205.
- 46 Einfeld DA, Schroeder R, Roelvink PW, Lizonova A, King CR, Kovesdi I, Wickham TJ. Reducing the native tropism of adenovirus vectors requires removal of both CAR and integrin interactions. J Virol 2001; 75: 11284–91.
- 47 Mizuguchi H, Koizumi N, Hosono T, Ishii-Watabe A, Uchida E, Utoguchi N, Watanabe Y, Hayakawa T. CAR- or αV integrin-binding ablated adenovirus vectors, but not fiber-modified vectors containing RGD peptide, do not change the systemic gene transfer properties in mice. Gene Ther 2002; 9: 769–76.
- 48 Danen EH, van Kraats AA, Cornelissen IM, Ruiter DJ, van Muijen GN. Integrin beta 3 cDNA transfection into a highly metastatic αVβ3-negative human melanoma cell line inhibits invasion and experimental metastasis. Biochem Biophys Res Commun 1996: 226: 75–81.